Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Mantel

Showing results (101-110 of 284) with videos related to

Pageof 29
Sort By:
International Journal of Technology Assessment in Health Care|November 17, 2025
Coverage with evidence development for medicines with insufficient evidence of clinical benefit: experience from the NetherlandsJan-Willem Versteeg, Noraly Stam, Aukje K Mantel-Teeuwisse, et al.
Clinical Pharmacology and Therapeutics|September 12, 2019
Concomitant Anticoagulant and Antidepressant Therapy in Atrial Fibrillation Patients and Risk of Stroke and BleedingJoris J Komen, Paul Hjemdahl, Aukje K Mantel-Teeuwisse, et al.
Pediatric Diabetes|April 25, 2017
Psychiatric medication use before and after the onset of type 1 diabetes in children and adolescents: A population-based cohort studySoulmaz Fazeli Farsani, Heshu Abdullah-Koolmees, Patrick C Souverein, et al.
Obesity (Silver Spring, Md.)|August 23, 2008
Psychiatric and cardiovascular comorbidities in patients with diabetes mellitus starting antiobesity drugsMarjolein J Willemen, Aukje K Mantel-Teeuwisse, Sabine M Straus, et al.
British Journal of Clinical Pharmacology|December 21, 2002
Limited adherence to safety instructions in drug leafletsH J Derijks, G H P De Koning, A K Mantel-Teeuwisse, et al.
Patient Preference and Adherence|December 7, 2016
Adverse events and patients' perceived health-related quality of life at the end of multidrug-resistant tuberculosis treatment in NamibiaEvans L Sagwa, Nunurai Ruswa, Farai Mavhunga, et al.
Plos One|February 18, 2014
Essential medicines are more available than other medicines around the globeYaser T Bazargani, Margaret Ewen, Anthonius de Boer, et al.
Health Policy (Amsterdam, Netherlands)|October 3, 2023
A systematic review of policies regulating or removing mark-ups in the pharmaceutical supply and distribution chainIris R Joosse, David Tordrup, Julie Glanville, et al.
European Journal of Public Health|January 12, 2018
Change in parental knowledge, attitudes and practice of antibiotic use after a national intervention programmeVerica Ivanovska, Bistra Angelovska, Liset van Dijk, et al.
Drug Discovery Today|November 11, 2015
Characteristics of product recalls of biopharmaceuticals and small-molecule drugs in the USAHans C Ebbers, Nina Fuentes de Tienda, Marcel C Hoefnagel, et al.
Pageof 29

Showing results (101-110 of 284) with videos related to

Sort By:
Pageof 29
International Journal of Technology Assessment in Health Care|November 17, 2025
Coverage with evidence development for medicines with insufficient evidence of clinical benefit: experience from the NetherlandsJan-Willem Versteeg, Noraly Stam, Aukje K Mantel-Teeuwisse, et al.
Clinical Pharmacology and Therapeutics|September 12, 2019
Concomitant Anticoagulant and Antidepressant Therapy in Atrial Fibrillation Patients and Risk of Stroke and BleedingJoris J Komen, Paul Hjemdahl, Aukje K Mantel-Teeuwisse, et al.
Pediatric Diabetes|April 25, 2017
Psychiatric medication use before and after the onset of type 1 diabetes in children and adolescents: A population-based cohort studySoulmaz Fazeli Farsani, Heshu Abdullah-Koolmees, Patrick C Souverein, et al.
Obesity (Silver Spring, Md.)|August 23, 2008
Psychiatric and cardiovascular comorbidities in patients with diabetes mellitus starting antiobesity drugsMarjolein J Willemen, Aukje K Mantel-Teeuwisse, Sabine M Straus, et al.
British Journal of Clinical Pharmacology|December 21, 2002
Limited adherence to safety instructions in drug leafletsH J Derijks, G H P De Koning, A K Mantel-Teeuwisse, et al.
Patient Preference and Adherence|December 7, 2016
Adverse events and patients' perceived health-related quality of life at the end of multidrug-resistant tuberculosis treatment in NamibiaEvans L Sagwa, Nunurai Ruswa, Farai Mavhunga, et al.
Plos One|February 18, 2014
Essential medicines are more available than other medicines around the globeYaser T Bazargani, Margaret Ewen, Anthonius de Boer, et al.
Health Policy (Amsterdam, Netherlands)|October 3, 2023
A systematic review of policies regulating or removing mark-ups in the pharmaceutical supply and distribution chainIris R Joosse, David Tordrup, Julie Glanville, et al.
European Journal of Public Health|January 12, 2018
Change in parental knowledge, attitudes and practice of antibiotic use after a national intervention programmeVerica Ivanovska, Bistra Angelovska, Liset van Dijk, et al.
Drug Discovery Today|November 11, 2015
Characteristics of product recalls of biopharmaceuticals and small-molecule drugs in the USAHans C Ebbers, Nina Fuentes de Tienda, Marcel C Hoefnagel, et al.
Pageof 29